During ablation for atrial fibrillation, is simultaneous renal artery ablation appropriate?
Over the past few decades, the mainstay of hypertension management has been pharmacological therapy; however, there is now a growing body of evidence that drug-resistant hypertension can be managed effectively by renal artery ablation. Several studies have documented the feasibility and safety of this treatment, although data regarding long-term outcomes are still emerging. Atrial fibrillation (AF) and hypertension commonly coexist, and recent work has demonstrated improved outcomes from catheter ablation of AF with concomitant renal artery denervation at little extra cost in terms of time and resource. The aim of this review is to explore the link between hypertension and AF, the synergistic effect of renal artery ablation on AF ablation, explain how this may work and address unanswered questions.
Department of Cardiology, Leeds General Infirmary, Leeds, UK.
A J
AJ
Hogarth
L E
LE
Dobson
M H
MH
Tayebjee
D000818:Animals; D001281:Atrial Fibrillation / Q000150:complications* / Q000517:prevention & control; D017115:Catheter Ablation; D006801:Humans; D006973:Hypertension / Q000150:complications* / Q000503:physiopathology / Q000628:therapy; D012077:Renal Artery / Q000294:innervation*; D013564:Sympathetic Nervous System / Q000503:physiopathology